Report of Foreign Issuer (6-k)

 

FORM 6-K

 

 

SECURITIES AND EXCHANGE COMMISSION 


Washington D.C. 20549

 

 

Report of Foreign Issuer

 

 

Pursuant to Rule 13a-16 or 15d-16 of 


the Securities Exchange Act of 1934

 

 

 

For period ending 12 August 2016

 

GlaxoSmithKline plc

(Name of registrant) 


 

 

 

980 Great West Road, Brentford, Middlesex, TW8 9GS

(Address of principal executive offices) 


 

 

 

Indicate by check mark whether the registrant files or

will file annual reports under cover Form 20-F or Form 40-F 


 

 

 

Form 20-F x     Form 40-F 


 

-- 


 

Indicate by check mark whether the registrant by furnishing the

information contained in this Form is also thereby furnishing the

information to the Commission pursuant to Rule 12g3-2(b) under the

Securities Exchange Act of 1934. 


 

 

 

Yes      No x

 

 

 

 

 

 

 

 

 

GlaxoSmithKline plc (the ' Company ')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mrs V A Whyte
b)	Position/status	Company Secretary
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each "Ordinary Shares" ISIN: GB0009252882
b)	Nature of the transaction	Transfer of Ordinary Shares to spouse for nil consideration.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£0.00	2,941
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2016-08-11
f)	Place of the transaction	n/a

 

 

 

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr I W Whyte
b)	Position/status	PCA of Mrs V A Whyte (Company Secretary)
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each "Ordinary Shares" ISIN: GB0009252882
b)	Nature of the transaction	Receipt of Ordinary Shares following transfer from spouse for nil consideration.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£0.00	2,941
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2016-08-11
f)	Place of the transaction	n/a

 

 

 

 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised. 


 

 

 

GlaxoSmithKline plc

(Registrant) 


Date: August 12, 2016 

 

 

By: VICTORIA WHYTE

----------------------

 

 

Victoria Whyte

Authorised Signatory for and on

behalf of GlaxoSmithKline plc